Johnson & Johnson lifts forecast on lower costs
NEW YORK: Johnson & Johnson (J&J) has halved its expectations for costs this year related to new tariffs and raised its full-year sales and profit forecasts after a strong quarter for flagship cancer drug Darzalex and its cardiovascular devices.
The company's shares rose 5.9% to US$164.29 in Wednesday's morning trade.
J&J said it now expects about US$200mil in tariff-related costs this year, exclusively tied to its medical devices unit, saying it had benefited from the Trump administration's pause on China levies and other duties.
It had previously pegged costs at about US$400mil starting in the second quarter (2Q25).
J&J's chief financial officer Joe Wolk told Reuters the company was able to absorb those costs and still raise its profit outlook, adding that he expected the impact this year to be minimal.
He noted that it was too soon to predict tariff impacts for 2026: 'It's such a fluid environment, we'll have to wait and see.'
The company will look to reinvest the difference in its product pipeline, a J&J executive said during an investor call.
Imports from most major trading partners are currently subject to levies of at least 10%, but in recent days US President Donald Trump has threatened 30% tariffs on the European Union and 50% on Brazil.
Trump plans separate pharmaceutical tariffs and recently said they could be delayed, but eventually be as high as 200%.
China is a key market for J&J's device business, although it does not reveal how much revenue it generates from the country.
'For J&J, it's mostly what they sell into China,' said Jeff Jonas, portfolio manager at Gabelli Funds, which owns shares of the company.
Jonas added that while the final rate of tariffs remains unknown, J&J has made the necessary cost cuts to offset impact.
The drug and medical device maker beat Wall Street expectations for 2Q25, posting adjusted earnings of US$2.77 per share versus analyst expectations of US$2.68 per share, according to data compiled by LSEG.
Quarterly sales stood at US$23.74bil, beating analysts' expectations of US$22.84bil.
Citing robust quarterly performance, J&J raised its 2024 sales forecast by about US$2bil and above analyst expectations of US$91.5bil, upping its range to US$93.2bil to US$93.6bil.
J&J said it expects to earn US$10.80 to US$10.90 per share on an adjusted basis in 2025, compared with its previous forecast of US$10.50 to US$10.70 per share.
JP Morgan analyst Chris Schott said in a note that J&J's roughly US 25 cents profit guidance boost outpaced expectations, but about 17 US cents of that comes from a weaker dollar.
He added that he sees the drugmaker's core business as strong and on track for consistent 5% or more sales growth.
The drugmaker's outlook excludes any effects from Trump's 'most favoured nation' drug pricing order from May, a J&J executive said during an investor call.
The order directs pharma companies to slash US drug prices to international levels.
Excluding foreign currency impact, medical device sales jumped 6.1% to US$8.54bil, outpacing predictions of US$8.25bil.
J&J saw gains from new products including Varipulse and Trupulse, which are used for pulsed field ablation, as well as double-digit growth for Abiomed products, specifically its Impella heart pumps.
Jonas said he was surprised by the stock increase, given that strong medical device volumes had been mostly anticipated, with both insurers and hospitals indicating robust surgical activity during the quarter.
J&J is betting on cardiovascular and surgery – especially with its move into robotics – as the key engines of growth for its medtech unit, an executive said during the investor call. Darzalex, a blood cancer therapy launched in 2015, brought in 2Q25 sales of US$3.54bil, compared with analysts' expectations of US$3.38bil. — Reuters
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
3 hours ago
- The Sun
China's rare earth magnet exports to US surge 660% in June
BEIJING: China's exports of rare earth magnets to the United States skyrocketed in June, surging more than six times compared to May. The rebound follows a trade agreement between the two nations, easing restrictions on critical minerals essential for electric vehicles and wind turbines. Customs data released on Sunday revealed shipments to the US surged to 353 metric tons in June, a 660% increase from the previous month. The recovery comes after negotiations in June resolved trade disputes, including Nvidia's plan to resume sales of its H20 AI chips to China. China, responsible for over 90% of global rare earth magnet supply, had imposed export restrictions in April in response to US tariffs. The move led to severe shortages, disrupting supply chains and forcing some automakers outside China to halt production temporarily. Total exports of rare earth permanent magnets in June reached 3,188 tons, a 157.5% rise from May. However, the figure remains 38.1% lower than June 2024 levels. Analysts expect further recovery in July as more exporters secure necessary licenses. In the first half of 2025, China's rare earth magnet exports fell 18.9% year-on-year to 22,319 tons. - Reuters
New Straits Times
4 hours ago
- New Straits Times
China starts construction of Tibet mega-dam
BEIJING: China started building a mega-dam Saturday on a river running through Tibet and India, with Premier Li Qiang attending the commencement ceremony, state media said. Beijing approved the project in December on the river – known as Yarlung Tsangpo in Tibet and Brahmaputra in India – linking it to the country's carbon neutrality targets and economic goals in the Tibet region. "The electricity generated will be primarily transmitted to other regions for consumption, while also meeting local power needs in Tibet," state news agency Xinhua reported after the groundbreaking ceremony in southeastern Tibet's Nyingchi. Once built, the dam could dwarf the record-breaking Three Gorges Dam on the Yangtze River in central China – and have a potentially serious impact on millions of people downstream in India and Bangladesh. The project will entail constructing five hydropower stations, with the total investment estimated to be around 1.2 trillion yuan (US$167.1 billion), Xinhua said. India said in January it had raised concerns with China about the project in Tibet, saying it will "monitor and take necessary measures to protect our interests." China "has been urged to ensure that the interests of the downstream states of the Brahmaputra are not harmed by activities in upstream areas", India's foreign ministry said then. In December, Beijing's foreign ministry said that the project would not have any "negative impact" downstream, adding that China "will also maintain communication with countries at the lower reaches" of the river. Besides downstream concerns, environmentalists have also warned about the irreversible impact of such mega projects in the ecologically sensitive Tibetan plateau. Both India and China, neighbours and rival Asian powers, share thousands of kilometres of disputed borders, where tens of thousands of soldiers are posted on either side.
New Straits Times
5 hours ago
- New Straits Times
Sabah Blue Economy on track to yield RM3.25bil annually from marine harvests
KOTA KINABALU: The Sabah Blue Economy is estimated to yield 491,000 tonnes of marine harvests such as fish and prawns annually, with a value of RM3.25 billion, said Chief Minister Datuk Seri Hajiji Noor. He said marine harvesting is one of 14 components of the Blue Economy that can be explored, such as renewable ocean energy, blue carbon, tourism, maritime transport, and marine biotechnology, among others. "There is more to Blue Economy than just deep-sea harvesting," he said in a speech read by Sabah Finance Minister Datuk Seri Masidi Manjun at the International Business Review (IBR) ASEAN Awards here yesterday. Also present was IBR Asia Group founder, director and chief executive officer Datuk Beatrice Nirmala. The chief minister also said that one of the most exciting aspects of ocean energy is the Ocean Thermal Energy Conversion (OTEC), which harnesses energy from the oceans. "OTEC power plants are currently being planned to span across 500km of coastline and, in time, to be able to generate 20,000MW of green energy, an unprecedented scale globally. This is not only a gamechanger for the country, it is a gamechanger for the region," he said. Hajiji said the Blue Economy Industrial Park has been established in Kudat as part of three new industrial parks approved by the state government, along with Kota Belud and Beaufort, all strategically located to grow investment opportunities. On the investment front, Hajiji said Sabah had recorded RM17.41 billion from 73 companies in overall approved foreign and domestic investments in the manufacturing sector since September 2020, with 52 companies already setting up businesses in the state with a total investment of RM7.8 billion, creating 3,636 jobs. Between 2022 and 2024, Sabah received new investment proposals worth an additional RM42.3 billion, which will create 32,996 jobs, he added. The chief minister highlighted that Sabah had sealed the Commercial Collaborative Agreement with Petronas, allowing the state to have more participation in the oil and gas industry. This includes 50 per cent equity from the Samarang oil and gas field, 25 per cent equity from Samur, and a 25 per cent equity in the US$3.1 billion (US$1=RM4.24) floating liquefied natural gas (ZLNG) investment in Sipitang. To support the growing investments, the state government has launched the Sabah Energy Roadmap and Master Plan 2040. This initiative aims to generate 700MW within the next 1 to 2 years. Additionally, the government has allocated RM679.85 million in 2024 to address immediate water shortages. Long-term plans also include the completion of the Ulu Padas hydropower. Meanwhile, nine winners were announced at the event, namely Institut Jantung Negara for corporate excellence in the healthcare sector, Clean Kinetics Pte Ltd for corporate excellence in the renewable energy sector, Millenium Minerals Ltd for corporate excellence in the mining industry, Sabah Port Sdn Bhd for corporate excellence in the logistics sector, AiRTS Pte Ltd for innovative technology in the artificial intelligence sector, Alpine Integrated Solution Sdn Bhd for corporate excellence in the event management sector, and Education Malaysia Global Services for corporate excellence in the education sector. Negeri Sembilan was named Most Progressive State in Malaysia in 2024, while Sabah was recognised as the Most Outstanding State in Malaysia for 2024.
